Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatic encephalopathies].

W Gerok1

  • 1Medizinische Univ.-Klinik, Freiburg.

Infusionstherapie Und Klinische Ernahrung
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Hepatic encephalopathy involves central nervous system disturbances caused by neurotoxins and amino acid imbalances. Branched-chain amino acids offer a new therapeutic approach by aiding ammonia detoxification in the brain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Professor Dr. Dieter Häussinger on his 60th birthday].

Zeitschrift fur Gastroenterologie·2011
Same author

[Pathophysiology of chronic diarrhea].

Praxis·2000
Same author

Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.

International journal of cancer·1998
Same author

[Significance of philosophy, bio-mathematics, biometry and model theory for medicine].

Medizinische Klinik (Munich, Germany : 1983)·1998
Same author

[New hepatitis viruses].

Praxis·1997
Same author

Uptake of 3 alpha, 7 alpha, 12 alpha-trihydroxy-24-nor-5 beta-cholan-23-sulfonate into isolated rat hepatocytes by three transport systems.

Journal of lipid research·1997

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gastroenterology

Context:

  • Hepatic encephalopathy (HE) presents complex central nervous system (CNS) functional disturbances.
  • Pathogenesis involves endogenous neurotoxins, amino acid imbalance, and blood-brain barrier alterations.
  • These factors disrupt neurotransmitter systems and their receptors.

Purpose:

  • To explore the pathogenetic factors contributing to CNS disturbances in hepatic encephalopathy.
  • To review current therapeutic strategies targeting ammonia production.
  • To introduce and evaluate the novel therapeutic concept of branched-chain amino acid (BCAA) application.

Summary:

  • HE pathogenesis is multifactorial, including neurotoxins, amino acid dysregulation, and compromised blood-brain barrier.

Related Experiment Videos

  • Current treatments focus on reducing ammonia production via protein restriction, lactulose, or antibiotics.
  • BCAAs represent a new strategy, promoting protein synthesis, urea production, and ammonia detoxification through glutamine synthesis.

    • Impact:

    • Understanding HE pathogenesis is crucial for developing effective treatments.
    • BCAA supplementation shows promise in enhancing ammonia detoxification and managing HE.
    • This research highlights a potential shift towards targeted metabolic interventions in HE therapy.